Agile market access

One would expect that routines have emerged from the participants involved in the more than 300 German early benefit assessment procedures, based on AMNOG, which is seen by the authorities as a "learning system". Instead, uncertainties and ambivalences within the process are rising. The launch of a new product to the market should overall be understood as an interdisciplinary and transfunctional task, performed by existing experts who are interlocked with each other, working together towards a common goal: the preferably sustainable, successful positioning of the new product on the German pharma market. 

We recommend the establishment of agile working methods to address these issues appropriately and efficiently. Using agile working methods can reduce the period for writing, compiling and completing an AMNOG value dossier by at least one third.